MACERICH CO/THE (MAC) Fundamental Analysis & Valuation

NYSE:MAC • US5543821012

19.22 USD
+0.42 (+2.23%)
At close: Mar 9, 2026
19.22 USD
0 (0%)
After Hours: 3/9/2026, 8:18:28 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to MAC. MAC was compared to 123 industry peers in the Diversified REITs industry. MAC may be in some trouble as it scores bad on both profitability and health. MAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. MAC Profitability Analysis

1.1 Basic Checks

  • MAC had negative earnings in the past year.
  • MAC had a positive operating cash flow in the past year.
  • In the past 5 years MAC reported 4 times negative net income.
  • In the past 5 years MAC always reported a positive cash flow from operatings.
MAC Yearly Net Income VS EBIT VS OCF VS FCFMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • With a Return On Assets value of -2.37%, MAC is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
  • MAC's Return On Equity of -8.08% is on the low side compared to the rest of the industry. MAC is outperformed by 73.17% of its industry peers.
  • MAC has a Return On Invested Capital of 1.69%. This is in the lower half of the industry: MAC underperforms 69.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MAC is in line with the industry average of 3.14%.
Industry RankSector Rank
ROA -2.37%
ROE -8.08%
ROIC 1.69%
ROA(3y)-2.77%
ROA(5y)-1.79%
ROE(3y)-8.8%
ROE(5y)-5.66%
ROIC(3y)1.76%
ROIC(5y)1.61%
MAC Yearly ROA, ROE, ROICMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • MAC has a worse Operating Margin (16.54%) than 61.79% of its industry peers.
  • In the last couple of years the Operating Margin of MAC has grown nicely.
  • Looking at the Gross Margin, with a value of 54.87%, MAC is doing worse than 71.54% of the companies in the same industry.
  • MAC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.54%
PM (TTM) N/A
GM 54.87%
OM growth 3Y-1.78%
OM growth 5Y8.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y-0.31%
MAC Yearly Profit, Operating, Gross MarginsMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MAC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAC is destroying value.
  • The number of shares outstanding for MAC has been increased compared to 1 year ago.
  • The number of shares outstanding for MAC has been increased compared to 5 years ago.
  • Compared to 1 year ago, MAC has a worse debt to assets ratio.
MAC Yearly Shares OutstandingMAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
MAC Yearly Total Debt VS Total AssetsMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.03, we must say that MAC is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.03, MAC is not doing good in the industry: 72.36% of the companies in the same industry are doing better.
  • MAC has a Debt/Equity ratio of 2.07. This is a high value indicating a heavy dependency on external financing.
  • MAC's Debt to Equity ratio of 2.07 is on the low side compared to the rest of the industry. MAC is outperformed by 69.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Altman-Z 0.03
ROIC/WACC0.27
WACC6.23%
MAC Yearly LT Debt VS Equity VS FCFMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • MAC has a Current Ratio of 0.83. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MAC has a Current ratio of 0.83. This is comparable to the rest of the industry: MAC outperforms 47.97% of its industry peers.
  • A Quick Ratio of 0.83 indicates that MAC may have some problems paying its short term obligations.
  • MAC has a Quick ratio (0.83) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
MAC Yearly Current Assets VS Current LiabilitesMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MAC Growth Analysis

3.1 Past

  • MAC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.10%.
  • MAC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.03%.
  • The Revenue has been growing slightly by 5.23% on average over the past years.
EPS 1Y (TTM)6.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.13%
Revenue 1Y (TTM)-10.03%
Revenue growth 3Y5.68%
Revenue growth 5Y5.23%
Sales Q2Q%-4.37%

3.2 Future

  • MAC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.34% yearly.
  • Based on estimates for the next years, MAC will show a small growth in Revenue. The Revenue will grow by 2.05% on average per year.
EPS Next Y82.95%
EPS Next 2Y39.84%
EPS Next 3Y28.95%
EPS Next 5Y16.34%
Revenue Next Year-1.05%
Revenue Next 2Y1.6%
Revenue Next 3Y0.24%
Revenue Next 5Y2.05%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MAC Yearly Revenue VS EstimatesMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
MAC Yearly EPS VS EstimatesMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. MAC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MAC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAC Price Earnings VS Forward Price EarningsMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • 71.54% of the companies in the same industry are cheaper than MAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.94
MAC Per share dataMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MAC's earnings are expected to grow with 28.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.84%
EPS Next 3Y28.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. MAC Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.43%, MAC has a reasonable but not impressive dividend return.
  • MAC's Dividend Yield is slightly below the industry average, which is at 7.58.
  • MAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

  • The dividend of MAC decreases each year by -9.22%.
  • MAC has paid a dividend for at least 10 years, which is a reliable track record.
  • MAC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-9.22%
Div Incr Years0
Div Non Decr Years3
MAC Yearly Dividends per shareMAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of MAC are negative and hence is the payout ratio. MAC will probably not be able to sustain this dividend level.
DP-87.85%
EPS Next 2Y39.84%
EPS Next 3Y28.95%
MAC Yearly Income VS Free CF VS DividendMAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

MAC Fundamentals: All Metrics, Ratios and Statistics

MACERICH CO/THE

NYSE:MAC (3/9/2026, 8:18:28 PM)

After market: 19.22 0 (0%)

19.22

+0.42 (+2.23%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners106.68%
Inst Owner Change1.47%
Ins Owners0.31%
Ins Owner Change-0.02%
Market Cap4.93B
Revenue(TTM)1.01B
Net Income(TTM)-197.92M
Analysts71
Price Target21.15 (10.04%)
Short Float %6.27%
Short Ratio7.98
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly Dividend0.68
Dividend Growth(5Y)-9.22%
DP-87.85%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-16
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-361.99%
Min EPS beat(2)-403.18%
Max EPS beat(2)-320.79%
EPS beat(4)0
Avg EPS beat(4)-241.51%
Min EPS beat(4)-403.18%
Max EPS beat(4)-94.54%
EPS beat(8)1
Avg EPS beat(8)-272.7%
EPS beat(12)3
Avg EPS beat(12)-376.24%
EPS beat(16)3
Avg EPS beat(16)-326.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.51%
Revenue beat(4)3
Avg Revenue beat(4)3.38%
Min Revenue beat(4)-2%
Max Revenue beat(4)12.16%
Revenue beat(8)6
Avg Revenue beat(8)5.52%
Revenue beat(12)10
Avg Revenue beat(12)4.68%
Revenue beat(16)12
Avg Revenue beat(16)3.67%
PT rev (1m)4.04%
PT rev (3m)5.94%
EPS NQ rev (1m)-3.26%
EPS NQ rev (3m)-3.26%
EPS NY rev (1m)24.09%
EPS NY rev (3m)9.57%
Revenue NQ rev (1m)-3.6%
Revenue NQ rev (3m)-4.55%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-3.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.87
P/FCF N/A
P/OCF 15.34
P/B 2.01
P/tB 2.18
EV/EBITDA 17.94
EPS(TTM)-0.77
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)1.25
OCFY6.52%
SpS3.95
BVpS9.54
TBVpS8.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.37%
ROE -8.08%
ROCE 2.14%
ROIC 1.69%
ROICexc 1.75%
ROICexgc 1.83%
OM 16.54%
PM (TTM) N/A
GM 54.87%
FCFM N/A
ROA(3y)-2.77%
ROA(5y)-1.79%
ROE(3y)-8.8%
ROE(5y)-5.66%
ROIC(3y)1.76%
ROIC(5y)1.61%
ROICexc(3y)1.79%
ROICexc(5y)1.64%
ROICexgc(3y)1.87%
ROICexgc(5y)1.7%
ROCE(3y)2.23%
ROCE(5y)2.04%
ROICexgc growth 3Y4.29%
ROICexgc growth 5Y16.17%
ROICexc growth 3Y3.86%
ROICexc growth 5Y15.96%
OM growth 3Y-1.78%
OM growth 5Y8.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.19%
GM growth 5Y-0.31%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF N/A
Debt/EBITDA 9.46
Cap/Depr 90.56%
Cap/Sales 32.87%
Interest Coverage 0.81
Cash Conversion 60.02%
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z 0.03
F-Score5
WACC6.23%
ROIC/WACC0.27
Cap/Depr(3y)68.79%
Cap/Depr(5y)48.26%
Cap/Sales(3y)23.85%
Cap/Sales(5y)16.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.13%
EPS Next Y82.95%
EPS Next 2Y39.84%
EPS Next 3Y28.95%
EPS Next 5Y16.34%
Revenue 1Y (TTM)-10.03%
Revenue growth 3Y5.68%
Revenue growth 5Y5.23%
Sales Q2Q%-4.37%
Revenue Next Year-1.05%
Revenue Next 2Y1.6%
Revenue Next 3Y0.24%
Revenue Next 5Y2.05%
EBIT growth 1Y-13.48%
EBIT growth 3Y3.8%
EBIT growth 5Y13.72%
EBIT Next Year220.14%
EBIT Next 3Y52.41%
EBIT Next 5Y26.41%
FCF growth 1Y-121.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.46%
OCF growth 3Y-1.6%
OCF growth 5Y20.84%

MACERICH CO/THE / MAC FAQ

What is the fundamental rating for MAC stock?

ChartMill assigns a fundamental rating of 1 / 10 to MAC.


Can you provide the valuation status for MACERICH CO/THE?

ChartMill assigns a valuation rating of 1 / 10 to MACERICH CO/THE (MAC). This can be considered as Overvalued.


How profitable is MACERICH CO/THE (MAC) stock?

MACERICH CO/THE (MAC) has a profitability rating of 2 / 10.


What is the financial health of MACERICH CO/THE (MAC) stock?

The financial health rating of MACERICH CO/THE (MAC) is 0 / 10.